Eli Lilly & Co. (LLY) Reports In-Line Q3 EPS; Narrows FY11 EPS Outlook
Tweet
Share
E-mailGet Alerts LLY Hot Sheet
Price: $1,145.86 +2.70%
Revenue Growth %: +25.9%
Financial Fact:
Cost of sales: 1.4B
Today's EPS Names:
OCCI, VIVO, PMCB, More
Revenue Growth %: +25.9%
Financial Fact:
Cost of sales: 1.4B
Today's EPS Names:
OCCI, VIVO, PMCB, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q3 EPS of $1.13, in-line with the analyst estimate of $1.13. Revenue for the quarter came in at $0 versus the consensus estimate of $6.06 billion.
Eli Lilly & Co. sees FY2011 EPS of $4.30-$4.35, versus prior guidance of $4.25-$4.35 and the consensus of $4.33.
Eli Lilly & Co. sees FY2011 EPS of $4.30-$4.35, versus prior guidance of $4.25-$4.35 and the consensus of $4.33.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh
- Zumiez, Inc. (ZUMZ) Misses Q2 EPS by 6c, Misses on Revenue; Offers Q3 Guidance
- Skillsoft (SKIL) Tops Q2 EPS by 14c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
